QBS72S: Overcoming Barriers to Cancer Treatment

Quadriga is developing QBS72S, a novel, first-in-class chemotherapeutic agent that is transported by L-type Amino Acid Transporter 1 (LAT1) across the blood brain barrier and into rapidly growing cancer cells.

QBS72S is designed to act as a “Trojan Horse” by mimicking the structure of an aromatic amino acid. This enables access through the blood brain barrier and into cancer cells, mediated by the L-type Amino Acid Transporter (LAT1). Once inside, QBS72S forms DNA interstrand cross-links that ultimately lead to cell death.

Advancing Novel Oncology Therapeutics

Find out more information about the company at the pages below.

About Quadriga

Quadriga is comprised of oncology drug development leaders committed to the advancement of QBS72S.

Latest News

Stay up-to-date with the latest
announcements, publications, and
more from Quadriga.

Contact Us

Interested in partnering?
Reach out here for
more information.